Literature DB >> 32668133

Improving Clinical Trial Enrollment - In the Covid-19 Era and Beyond.

Crystal M North1, Michael L Dougan1, Chana A Sacks1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32668133     DOI: 10.1056/NEJMp2019989

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial.

Authors:  Zhe Kang Law; Jason P Appleton; Polly Scutt; Ian Roberts; Rustam Al-Shahi Salman; Timothy J England; David J Werring; Thompson Robinson; Kailash Krishnan; Robert A Dineen; Ann Charlotte Laska; Philippe A Lyrer; Juan Jose Egea-Guerrero; Michal Karlinski; Hanne Christensen; Christine Roffe; Daniel Bereczki; Serefnur Ozturk; Jegan Thanabalan; Ronan Collins; Maia Beridze; Alfonso Ciccone; Lelia Duley; Angela Shone; Philip M Bath; Nikola Sprigg
Journal:  Stroke       Date:  2021-12-01       Impact factor: 7.914

2.  Allocation of Opportunities to Participate in Clinical Trials during the Covid-19 Pandemic and Other Public Health Emergencies.

Authors:  Kayte Spector-Bagdady; Holly Fernandez Lynch; Barbara E Bierer; Luke Gelinas; Sara Chandros Hull; David Magnus; Michelle N Meyer; Richard R Sharp; Jeremy Sugarman; Benjamin S Wilfond; Ruqaiijah Yearby; Seema Mohapatra
Journal:  Hastings Cent Rep       Date:  2021-12-15       Impact factor: 4.298

Review 3.  The Impact of COVID-19 on National Clinical Trials Network Breast Cancer Trials.

Authors:  Amara Ndumele; Ko Un Park
Journal:  Curr Breast Cancer Rep       Date:  2021-05-12

4.  Is G-CSF Dangerous in COVID-19: Why Not Use GM-CSF?

Authors:  Hillard M Lazarus; Robert Peter Gale
Journal:  Acta Haematol       Date:  2020-11-06       Impact factor: 2.195

5.  Implementation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 (REMAP-COVID) trial in a US health system-lessons learned and recommendations.

Authors: 
Journal:  Trials       Date:  2021-01-28       Impact factor: 2.279

Review 6.  Strategies for Behavioral Research in Neurology: Lessons Learned During the COVID-19 Pandemic and Applications for the Future.

Authors:  Ami Z Cuneo; Kazi Maisha; Mia T Minen
Journal:  Curr Neurol Neurosci Rep       Date:  2021-10-27       Impact factor: 5.081

7.  Prediction of clinical trial enrollment rates.

Authors:  Cameron Bieganek; Constantin Aliferis; Sisi Ma
Journal:  PLoS One       Date:  2022-02-24       Impact factor: 3.752

8.  Prioritizing studies of COVID-19 and lessons learned.

Authors:  Dushyantha Jayaweera; Patrick A Flume; Nora G Singer; Myron S Cohen; Anne M Lachiewicz; Amanda Cameron; Naresh Kumar; Joel Thompson; Alyssa Cabrera; Denise Daudelin; Reza Shaker; Philippe R Bauer
Journal:  J Clin Transl Sci       Date:  2021-04-21

9.  How informative were early SARS-CoV-2 treatment and prevention trials? a longitudinal cohort analysis of trials registered on ClinicalTrials.gov.

Authors:  Nora Hutchinson; Katarzyna Klas; Benjamin G Carlisle; Jonathan Kimmelman; Marcin Waligora
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

10.  Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.

Authors:  John H Stone; Matthew J Frigault; Naomi J Serling-Boyd; Ana D Fernandes; Liam Harvey; Andrea S Foulkes; Nora K Horick; Brian C Healy; Ruta Shah; Ana Maria Bensaci; Ann E Woolley; Sarah Nikiforow; Nina Lin; Manish Sagar; Harry Schrager; David S Huckins; Matthew Axelrod; Michael D Pincus; Jorge Fleisher; Chana A Sacks; Michael Dougan; Crystal M North; Yuan-Di Halvorsen; Tara K Thurber; Zeina Dagher; Allison Scherer; Rachel S Wallwork; Arthur Y Kim; Sara Schoenfeld; Pritha Sen; Tomas G Neilan; Cory A Perugino; Sebastian H Unizony; Deborah S Collier; Mark A Matza; Janeth M Yinh; Kathryn A Bowman; Eric Meyerowitz; Amna Zafar; Zsofia D Drobni; Marcy B Bolster; Minna Kohler; Kristin M D'Silva; Jonathan Dau; Megan M Lockwood; Caroline Cubbison; Brittany N Weber; Michael K Mansour
Journal:  N Engl J Med       Date:  2020-10-21       Impact factor: 176.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.